Generic Name and Formulations:
Erenumab-aooe 70mg/mL; soln for SC inj; preservative-free.
Indications for AIMOVIG:
Prophylaxis of migraine.
Give by SC inj into abdomen, thigh, or upper arm. 70mg once monthly; some patients may benefit from 140mg (given as 2 consecutive 70mg inj) once monthly.
Do not inj into tender, bruised, red, or hard areas. Latex allergy. Elderly. Pregnancy. Nursing mothers.
Calcitonin gene-related peptide (CGRP) receptor antagonist.
Inj site reactions, constipation, cramps, muscle spasms.
Single-dose prefilled SureClick autoinjectors—1, 2; Single-dose prefilled syringes—1, 2
Neurology Advisor Articles
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Addressing Levodopa-Resistant Parkinson Disease
- High Daily Stress Linked to Migraine Prevalence in Women
- Researchers Identify Coffee Component That May Provide Neuroprotection
- Functional Imaging in Movement Disorders: Diagnostic Advantages
- Dextroamphetamine Plus Physical Therapy Nonsuperior to Placebo for Improving Post-Stroke Motor Recovery
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy